Gag protein epitopes recognized by CD4+ T-helper lymphocytes from equine infectious anemia virus-infected carrier horses

Journal of Virology

Volumn 73, Issue 5, 1999, Pages 4257-4265

  Lonning, S M ^a,b   Zhang, W ^a,c   McGuire, T C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CD4 ANTIGEN; EPITOPE; GAG PROTEIN; PROTEIN P15; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; EQUINE INFECTIOUS ANEMIA VIRUS; EXPERIMENTAL INFECTION; HELPER CELL; HORSE; IMMUNE RESPONSE; LENTIVIRINAE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

EID: 0032924192     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.5.4257-4265.1999     Document Type: Article

References (49)

1. An, L. L., and J. L. Whilton. 1997. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen. J. Virol. 71:2292-2302.
2. Baba, E., M. Nakamura, K. Ohkuma, J. Kira, Y. Tanaka, S. Nakano, and Y. Niho. 1995. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies. J. Immunol. 154:399-412.
3. +-T-cell-deficient mice. J. Virol. 68:4700-4704.
4. Berzofsky, J. A. 1991. Development of artificial vaccines against HIV using defined epitopes. FASEB J. 5:2412-2418.
5. Blazevic, V., A. Ranki, and K. J. Krohn. 1995. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev. AIDS Res. Hum. Retroviruses 11:1335-1342.
6. Chong, Y. H., S. L. Payne, C. J. Issel, R. C. Montelaro, and K. E. Rushlow. 1991. Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus. J. Virol. 65:1007-1012.
7. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
8. Desrosiers, R. C. 1992. HIV with multiple gene deletions as a live attenuated vaccine for AIDS. AIDS Res. Hum. Retroviruses 8:411-421.
9. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362: 359-362.
10. Franke, E. D., G. Corradin, and S. L. Hoffman. 1997. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides. J. Immunol. 159:3424-3433.
11. Gerencer, M., I. Valpotic, B. Jukic, M. Tomaskovic, and I. Basic. 1989. Qualitative analyses of cellular immune functions in equine infectious anemia show homology with AIDS. Arch. Virol. 104:249-257.
12. Godfrey, D. I., J. Kennedy, M. K. Gately, J. Hakimi, B. R. Hubbard, and A. Zlotnik. 1994. IL-12 influences intrathymic T cell development. J. Immunol. 152:2729-2735.
13. Grund, C. H., E. R. Lechman, C. J. Issel, R. C. Montelaro, and K. E. Rushlow. 1994. Lentivirus cross-reactive determinants present in the capsid protein of equine infectious anaemia virus. J. Gen. Virol. 75:657-662.
14. Henderson, L. E., R. C. Sawder, G. W. Smythers, and S. Oroszlan. 1987. Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins. J. Virol. 61:1116-1124.
15. Issel, C. J., D. W. Horohov, D. F. Lea, W. V. Adams, Jr., S. D. Hagius, J. M. McManus, A. C. Allison, and R. C. Montelaro. 1992. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J. Virol. 66:3398-3408.
16. Kumar, A., R. Arora, P. Kaur, V. S. Chauhan, and P. Sharma. 1992. "Universal" T helper cell dete minants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. J. Immunol. 148:1499-1505.
17. Kydd, J., D. F. Antczak, W. R. Allen, D. Barbis, G. Butcher, W. Davis, W. P. Duffus, N. Edington, G. Grunig, M. A. Holmes, et al. 1994. Report of the First International Workshop on Equine Leucocyte Antigens, Cambridge, United Kingdom, July 1991. Vet. Immunol. Immunopathol. 42:3-60.
18. Lonning, S. M., W. Zhang, S. R. Leib, and T. C. McGuire. 1999. Detection and induction of equine infectious anemia virus-specific memory cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors. J. Virol. 73:2762-2769.
19. Malmquist, W. A., D. Barnett, and C. S. Becvar. 1973. Production of equine infectious anemia antigen in a persistently infected cell line. Arch. Gesamte Virusforsch. 42:361-370.
20. Mammano, F., A. Ohagen, S. Hoglund, and H. G. Gottlinger. 1994. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 68:4927-4936.
21. Matsuo, K., Y. Nishino, T. Kimura, R. Yamaguchi, A. Yamazaki, T. Mikami, and K. Ikuta. 1992. Highly conserved epitope domain in major core protein p24 is structurally similar among human, simian and feline immunodeficiency viruses. J. Gen. Virol. 73:2445-2450.
22. Maury, W. 1994. Monocyte maturation controls expression of equine infectious anemia virus. J. Virol. 68:6270-6279.
23. McGuire, T. C., D. S. Adams, G. C. Johnson, P. Kleyjer-Anderson, D. D. Barbee, and J. R. Gorham. 1986. Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats. Am. J. Vet. Res. 47:537-540.
24. McGuire, T. C., T. Harkins, S. R. Leib, and T. F. McElwain. Unpublished data.
25. McGuire, T. C., K. I. O'Rourke, T. V. Baszler, S. R. Leib, A. L. Brassfield, and W. C. Davis. 1994. Expression of functional protease and subviral particles by vaccinia virus containing equine infectious anaemia virus gag and 5′ pol genes. J. Gen. Virol. 75:895-900.
26. + cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J. Virol. 68:1459-1467.
27. Meister, G. E., C. G. Roberts, J. A. Berzofsky, and A. S. De-Groot. 1995. Two novel T cell epitope pre liction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Vaccine 13:581-591.
28. Montelaro, R. C., J. M. Ball, and K. E. Rushlow. 1993. Equine retroviruses, p. 257-360. In J. A. Levy (ed.), The Retroviridae. Plenum Press, New York, N.Y.
29. Montelaro, R. C., C. Grund, M. Raabe, B. Woodson, R. F. Cook, S. Cook, and C. J. Issel. 1996. Characterization of protective and enhancing immune responses to equine infectious anemia virus resulting from experimental vaccines. AIDS Res. Hum. Retroviruses 12:413-415.
30. Montelaro, R. C., W. G. Robey, M. D. West, C. J. Issel, and P. J. Fischinger. 1988. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus. J. Gen. Virol. 69:1711-1717.
31. Nakamura, Y., M. Kameoka, M. Tobiume, M. Kaya, K. Ohki, T. Yamada, and K. Ikuta. 1997. A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein. Vaccine 15:489-496.
32. Obeid, O. E., C. D. Partidos, and M. W. Steward. 1993. Identification of helper T cell antigenic sites in mice from the haemagglutinin glycoprotein of measles virus. J. Gen. Virol. 74:2549-2557.
33. Oldstone, M. B. 1997. How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. Virology 234:179-185.
34. O'Rourke, K., L. E. Perryman, and T. C. McGuire. 1988. Antiviral, antiglycoprotein and neutral zing antibodies in foals with equine infectious anemia virus. J. Gen. Virol. 69:667-674.
35. Partidos, C. D., P. Vohra, and M. W. Steward. 1996. Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides, Immunology 87:179-185.
36. Perryman, L. E., K. I. O'Rourke, P. H. Mason, and T. C. McGuire. 1990. Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaem a virus. Immunology 71:592-594.
37. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94:6874-6879.
38. + T cell responses associated with control of viremia. Science 278:1447-1450.
39. Rudensky, A. Y., H. P. Preston, S. C. Hong, A. Barlow, and C. A. J. Janeway. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622-627.
40. Sauzet, J. P., B. D'eprez, F. Martinon, J. G. Guillet, H. Gras Masse, and E. Gomard. 1995. Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides. Vaccine 13:1339-1345.
41. Shirai, M., M. Chen, T. Arichi, T. Masaki, M. Nishioka, M. Newman, T. Nakazawa, S. M. Feinstone, and J. A. Berzofsky. 1996. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines. J. Infect. Dis. 173:24-31.
42. + CTL in vivo with peptide vaccine constructs. J. Immunol. 152:549-556.
43. Stephens, R. M., J. W. Casey, and N. R. Rice. 1986. Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus. Science 231: 589-594.
44. Stuhler, G., and S. F. Schlossman. 1997. Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets. Proc. Natl. Acad. Sci. USA 94:622-627.
45. Stuhler, G., and P. Waiden. 1993. Collaboration of helper and cytotoxic T lymphocytes. Eur. J. Immunol. 23:2279-2286.
46. Takeda, A., C. U. Tuazon, and F. A. Ennis. 1988. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242:580-583.
47. Tumas, D. B., A. L. Brassfield, A. S. Travenor, M. T. Hines, W. C. Davis, and T. C. McGuire. 1994. Monoclonal antibodies to the equine CD2 T lymphocyte marker, to a pan-granulocyte/monocyte marker and to a unique pan-B lymphocyte marker. Immunobiology 192:48-64.
48. Wang, S. Z., K. E. Rushlow, C. J. Issel, R. F. Cook, S. J. Cook, M. L. Raabe, Y. H. Chong, L. Costa, and R. C. Montelaro. 1994. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology 199:247-251.
49. Zhang, W., S. M. Lonning, and T. C. McGuire. 1998. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J. Virol. 72:9612-9620.